GRIFFITH G C, LEVINSON D C
Calif Med. 1949 Dec;71(6):403-8.
Fifty-seven patients with subacute bacterial endocarditis were treated with doses of penicillin varying from 500,000 to 20,000,000 units per day. Diagnosis was confirmed in some cases by growths on blood culture, in others by postmortem examination. In those cases in which the diagnosis was established by blood culture, the in vitro sensitivity of the organism to penicillin was determined and penicillin then was administered by continuous intramuscular infusion in a dosage calculated to produce blood levels of penicillin four to five times that required for in vitro inhibition. Penicillin was given for a period of 21 days, and blood cultures were made periodically during and after treatment. Of the 57 patients, 38 were cured (66.7 per cent), and 19 died (33.3 per cent). Of the 19 who died, three did so within 48 hours of hospitalization and seven died despite adequate treatment. Of these seven, three died of cerebral emboli, two because of resistance to penicillin and streptomycin, one because of congestive heart failure, and one of undetermined cause. The remaining nine who died were considered to have been inadequately treated in that there was (1) failure to obtain sensitivity, (2) inadequate dossage of penicillin, (3) delay in starting treatment, or (4) failure to recognize mixed infections. There were five patients with repeatedly sterile blood cultures during life. In all of these cases, streptococcus viridans was recovered at postmortem examination. In an attempt to determine how long therapy should justly be withheld in patients with repeatedly sterile blood cultures, 140 cases of subacute bacterial endocarditis in which positive blood cultures had been obtained were reviewed. From the review it was determined that if blood cultures taken during the first two days are reported sterile, the chance of subsequent cultures proving positive is minimal. Therefore, for patients in whom the diagnosis seems otherwise obvious, delaying treatment for more than two days is not justified even though the blood culture be sterile. In cases in which blood cultures are repeatedly sterile, a dosage of 6,000,000 to 10,000,000 units of penicillin daily for 21 days is advisable.High bacterial resistance to penicillin and streptomycin was found in four fatal cases. In one of these, the infecting organism was streptococcus viridans, and in three it was staphylococcus albus. There was one patient with penumococcal meningitis complicated by unrecognized streptococcal viridans bacterial endocarditis.
57例亚急性细菌性心内膜炎患者接受了每日剂量从50万单位到2000万单位不等的青霉素治疗。部分病例通过血培养生长确诊,其他病例通过尸检确诊。在通过血培养确诊的病例中,测定了病原体对青霉素的体外敏感性,然后通过连续肌肉输注给予青霉素,剂量计算为使青霉素血药浓度达到体外抑制所需浓度的4至5倍。青霉素给药21天,治疗期间及治疗后定期进行血培养。57例患者中,38例治愈(66.7%),19例死亡(33.3%)。19例死亡患者中,3例在住院48小时内死亡,7例尽管治疗充分仍死亡。这7例中,3例死于脑栓塞,2例因对青霉素和链霉素耐药死亡,1例因充血性心力衰竭死亡,1例死因不明。其余9例死亡患者被认为治疗不充分,原因包括:(1)未获得敏感性结果;(2)青霉素剂量不足;(3)开始治疗延迟;(4)未识别混合感染。有5例患者生前血培养多次无菌。在所有这些病例中,尸检时均发现草绿色链球菌。为了确定对于血培养多次无菌的患者应合理延迟治疗多长时间,回顾了140例已获得阳性血培养结果的亚急性细菌性心内膜炎病例。通过回顾确定,如果头两天采集的血培养报告无菌,后续培养结果为阳性的可能性极小。因此,对于诊断似乎明确的患者,即使血培养无菌,延迟治疗超过两天也是不合理的。在血培养多次无菌的病例中,建议每日给予600万至1000万单位青霉素,持续21天。在4例死亡病例中发现对青霉素和链霉素的高细菌耐药性。其中1例感染病原体为草绿色链球菌,3例为白色葡萄球菌。有1例肺炎球菌脑膜炎患者并发未被识别的草绿色链球菌性心内膜炎。